Raymond James Financial Services Advisors »

Dyne Therapeutics shares owned by Raymond James Financial Services Advisors

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Raymond James Financial Services Advisors from 13F filings

Historical chart of Raymond James Financial Services Advisors investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Raymond James Financial Services Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Raymond James Financial Services Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $877k 31k 28.39

More positions owned by Raymond James Financial Services Advisors

Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Vanguard Index Fds Value Etf (VTV)
Home Depot (HD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Total Stk Mkt (VTI)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Raymond James Financial Services Advisors

Top funds holding Dyne Therapeutics

Atlas Venture Life Science Advisors
Fcpm Iii Services B.v.
Citadel Advisors
Vanguard Group
VR Adviser
Franklin Resources
Logos Global Management
Vivo Capital
Artal Group
Jennison Associates
Frazier Life Sciences Management
Goldman Sachs Group
Ikarian Capital
Commodore Capital
Dimensional Fund Advisors

View all funds holding Dyne Therapeutics